Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a clinical study for metastatic breast cancer and the addition of new collaborators and a revision number. The study's specific protocols and criteria have been deleted, which may impact the understanding of the study's design and objectives.SummaryDifference55%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 4, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to v2.14.3, replacing the previous date of February 4, 2025, and revision v2.14.2.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check87 days agoChange DetectedThe webpage has updated its service availability information, indicating that some NLM-NCBI services are experiencing heavy traffic, which may impact performance. Additionally, several future dates have been added while previous dates have been removed.SummaryDifference2%
Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.